Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Y. Wu

P2.01-18 Differential Molecular Mechanisms Associated With Dramatic and Gradual Progression in NSCLC Patients With Intrathoracic Dissemination

Journal of Thoracic Oncology

English

P2.04-29 Preliminary Results With Tislelizumab in Chinese Patients With Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

English

MA02.03 ASTRIS: A Real World Treatment Study of Osimertinib in Patients With EGFR T790m-Positive NSCLC

Journal of Thoracic Oncology

English

JCSE01.22 Differential Molecular Mechanisms Associated With Dramatic and Gradual Progression in NSCLC Patients With Intrathoracic Dissemination

Journal of Thoracic Oncology

English

P3.01-64 Preliminary Data of Diverse Therapies in Patients With Advanced Non–Small-Cell Lung Cancer Harbouring RET-Rearrangement

Journal of Thoracic Oncology

English

JCSE01.09 Cluster Trial: Ph2 Biomarker-Integrated Study of Single Agent Alpelisib, Capmatinib, Ceritinib and Binimetinib in advNSCLC

Journal of Thoracic Oncology

English

MA24.01 Genomic Evolution Trajectory Depicts Invasiveness Acquisition From Pre-Invasive to Invasive Adenocarcinoma

Journal of Thoracic Oncology

English

P1.11-18 a Classification-Based Machine Learning Method Reveals Exosomal miRNA Biomarkers for Patients With Pulmonary Ground Glass Nodule

Journal of Thoracic Oncology

English

P3.12-10 Immunogenomic Characteristics of SCLC and LCNEC Redefined Molecular Subgroups

Journal of Thoracic Oncology

English

P1.13-02 eXalt3: Phase 3 Randomized Study Comparing Ensartinib to Crizotinib in Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer Patients

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Y. Wu

P2.01-18 Differential Molecular Mechanisms Associated With Dramatic and Gradual Progression in NSCLC Patients With Intrathoracic Dissemination

P2.04-29 Preliminary Results With Tislelizumab in Chinese Patients With Non-Small Cell Lung Cancer (NSCLC)

MA02.03 ASTRIS: A Real World Treatment Study of Osimertinib in Patients With EGFR T790m-Positive NSCLC

JCSE01.22 Differential Molecular Mechanisms Associated With Dramatic and Gradual Progression in NSCLC Patients With Intrathoracic Dissemination

P3.01-64 Preliminary Data of Diverse Therapies in Patients With Advanced Non–Small-Cell Lung Cancer Harbouring RET-Rearrangement

JCSE01.09 Cluster Trial: Ph2 Biomarker-Integrated Study of Single Agent Alpelisib, Capmatinib, Ceritinib and Binimetinib in advNSCLC

MA24.01 Genomic Evolution Trajectory Depicts Invasiveness Acquisition From Pre-Invasive to Invasive Adenocarcinoma

P1.11-18 a Classification-Based Machine Learning Method Reveals Exosomal miRNA Biomarkers for Patients With Pulmonary Ground Glass Nodule

P3.12-10 Immunogenomic Characteristics of SCLC and LCNEC Redefined Molecular Subgroups

P1.13-02 eXalt3: Phase 3 Randomized Study Comparing Ensartinib to Crizotinib in Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer Patients